APA (7th ed.) Citation

Athyros, V. G., Boutari, C., Stavropoulos, K., Anagnostis, P., Imprialos, K. P., Doumas, M., & Karagiannis, A. (2018). Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk. Current vascular pharmacology, 16(3), 246. https://doi.org/10.2174/1570161115666170621082910

Chicago Style (17th ed.) Citation

Athyros, Vasilios G., Chrysa Boutari, Konstantinos Stavropoulos, Panagiotis Anagnostis, Konstantinos P. Imprialos, Michael Doumas, and Asterios Karagiannis. "Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk." Current Vascular Pharmacology 16, no. 3 (2018): 246. https://doi.org/10.2174/1570161115666170621082910.

MLA (9th ed.) Citation

Athyros, Vasilios G., et al. "Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk." Current Vascular Pharmacology, vol. 16, no. 3, 2018, p. 246, https://doi.org/10.2174/1570161115666170621082910.